Christian Hopfer
Concepts (407)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 39 | 2026 | 1098 | 3.590 |
Why?
| | Marijuana Abuse | 21 | 2024 | 215 | 3.320 |
Why?
| | Cannabis | 13 | 2025 | 519 | 2.900 |
Why?
| | Marijuana Use | 10 | 2026 | 218 | 2.450 |
Why?
| | Conduct Disorder | 16 | 2023 | 159 | 2.040 |
Why?
| | Adolescent Behavior | 16 | 2020 | 486 | 1.400 |
Why?
| | Alcoholism | 20 | 2025 | 830 | 1.350 |
Why?
| | Alcohol Drinking | 16 | 2024 | 847 | 1.320 |
Why?
| | Marijuana Smoking | 9 | 2022 | 248 | 1.300 |
Why?
| | Antisocial Personality Disorder | 16 | 2025 | 123 | 1.220 |
Why?
| | Social Environment | 10 | 2014 | 246 | 1.100 |
Why?
| | Tobacco Use Disorder | 11 | 2020 | 217 | 1.090 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2025 | 2228 | 1.040 |
Why?
| | Adolescent | 94 | 2026 | 22451 | 1.010 |
Why?
| | Siblings | 13 | 2025 | 196 | 0.950 |
Why?
| | Medical Marijuana | 4 | 2025 | 119 | 0.930 |
Why?
| | Genetic Predisposition to Disease | 17 | 2025 | 2455 | 0.920 |
Why?
| | Appetite | 1 | 2026 | 80 | 0.910 |
Why?
| | Twins | 10 | 2025 | 156 | 0.850 |
Why?
| | Smoking | 17 | 2019 | 1478 | 0.800 |
Why?
| | Genome-Wide Association Study | 15 | 2025 | 1526 | 0.770 |
Why?
| | Risk-Taking | 7 | 2019 | 321 | 0.680 |
Why?
| | Legislation, Drug | 4 | 2023 | 72 | 0.650 |
Why?
| | Humans | 132 | 2026 | 145625 | 0.650 |
Why?
| | Young Adult | 40 | 2026 | 14240 | 0.650 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 1158 | 0.650 |
Why?
| | Female | 100 | 2026 | 79080 | 0.640 |
Why?
| | Male | 98 | 2026 | 73014 | 0.640 |
Why?
| | Feeding Behavior | 1 | 2026 | 691 | 0.630 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 221 | 0.630 |
Why?
| | Mental Disorders | 9 | 2025 | 1133 | 0.620 |
Why?
| | Problem Behavior | 2 | 2018 | 97 | 0.610 |
Why?
| | Colorado | 23 | 2022 | 4588 | 0.600 |
Why?
| | Adult | 63 | 2026 | 40821 | 0.590 |
Why?
| | Dronabinol | 2 | 2020 | 250 | 0.590 |
Why?
| | Diseases in Twins | 4 | 2014 | 114 | 0.590 |
Why?
| | Cannabinol | 1 | 2019 | 1 | 0.580 |
Why?
| | Opioid-Related Disorders | 5 | 2021 | 611 | 0.570 |
Why?
| | Longitudinal Studies | 27 | 2026 | 3005 | 0.560 |
Why?
| | Homeless Youth | 3 | 2008 | 23 | 0.550 |
Why?
| | Hallucinogens | 1 | 2020 | 112 | 0.540 |
Why?
| | Criminals | 1 | 2018 | 34 | 0.540 |
Why?
| | Heroin Dependence | 3 | 2003 | 33 | 0.520 |
Why?
| | Sexual Behavior | 5 | 2019 | 489 | 0.510 |
Why?
| | Substance Abuse, Intravenous | 3 | 2016 | 131 | 0.510 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 142 | 0.510 |
Why?
| | Prescription Drug Misuse | 1 | 2017 | 53 | 0.500 |
Why?
| | Cigarette Smoking | 1 | 2018 | 103 | 0.500 |
Why?
| | Receptors, Nicotinic | 7 | 2016 | 327 | 0.490 |
Why?
| | Genetic Linkage | 3 | 2008 | 269 | 0.480 |
Why?
| | Prescription Drug Diversion | 1 | 2016 | 13 | 0.470 |
Why?
| | Prevalence | 11 | 2022 | 2852 | 0.450 |
Why?
| | Crohn Disease | 1 | 2019 | 249 | 0.440 |
Why?
| | Genotype | 15 | 2019 | 1866 | 0.440 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 6 | 2025 | 421 | 0.430 |
Why?
| | Motivation | 2 | 2018 | 601 | 0.410 |
Why?
| | Accidents, Traffic | 2 | 2018 | 192 | 0.400 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 352 | 0.390 |
Why?
| | Receptors, Dopamine D2 | 4 | 2007 | 93 | 0.390 |
Why?
| | Body Mass Index | 3 | 2018 | 2446 | 0.380 |
Why?
| | Family Health | 1 | 2014 | 192 | 0.380 |
Why?
| | Polymorphism, Genetic | 4 | 2016 | 611 | 0.370 |
Why?
| | Behavior, Addictive | 2 | 2026 | 89 | 0.370 |
Why?
| | Genetic Variation | 5 | 2022 | 992 | 0.350 |
Why?
| | Phenotype | 15 | 2025 | 3186 | 0.340 |
Why?
| | Comorbidity | 9 | 2016 | 1652 | 0.310 |
Why?
| | Surveys and Questionnaires | 13 | 2019 | 6050 | 0.300 |
Why?
| | Urban Population | 2 | 2012 | 496 | 0.290 |
Why?
| | Sleep | 3 | 2025 | 896 | 0.290 |
Why?
| | Child Abuse | 6 | 2021 | 545 | 0.290 |
Why?
| | Nurses, Community Health | 2 | 2019 | 38 | 0.290 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2019 | 184 | 0.290 |
Why?
| | Biological Specimen Banks | 4 | 2019 | 137 | 0.290 |
Why?
| | Substance Abuse Detection | 2 | 2020 | 110 | 0.290 |
Why?
| | Impulsive Behavior | 4 | 2017 | 146 | 0.280 |
Why?
| | Prenatal Care | 3 | 2019 | 310 | 0.280 |
Why?
| | United States | 18 | 2025 | 16041 | 0.280 |
Why?
| | Prospective Studies | 9 | 2020 | 8087 | 0.280 |
Why?
| | Criminal Behavior | 2 | 2018 | 5 | 0.280 |
Why?
| | Multifactorial Inheritance | 4 | 2025 | 242 | 0.280 |
Why?
| | United Kingdom | 3 | 2019 | 376 | 0.270 |
Why?
| | Haplotypes | 5 | 2009 | 505 | 0.270 |
Why?
| | Juvenile Delinquency | 5 | 2018 | 96 | 0.270 |
Why?
| | Adolescent Development | 2 | 2019 | 72 | 0.260 |
Why?
| | House Calls | 2 | 2019 | 154 | 0.260 |
Why?
| | Genetic Association Studies | 4 | 2021 | 376 | 0.260 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 12 | 0.250 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2006 | 36 | 0.250 |
Why?
| | Sex Factors | 10 | 2017 | 2101 | 0.250 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2006 | 43 | 0.250 |
Why?
| | Mental Health | 2 | 2025 | 771 | 0.250 |
Why?
| | Health Surveys | 5 | 2012 | 511 | 0.250 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5875 | 0.250 |
Why?
| | Cognition | 4 | 2020 | 1286 | 0.250 |
Why?
| | Case-Control Studies | 10 | 2019 | 3633 | 0.240 |
Why?
| | Multigene Family | 3 | 2013 | 209 | 0.240 |
Why?
| | Homosexuality | 1 | 2006 | 18 | 0.240 |
Why?
| | Analgesics | 2 | 2020 | 231 | 0.230 |
Why?
| | Home Care Services | 2 | 2019 | 290 | 0.230 |
Why?
| | Drug Prescriptions | 2 | 2018 | 290 | 0.230 |
Why?
| | Bisexuality | 1 | 2006 | 39 | 0.230 |
Why?
| | Anthropometry | 1 | 2026 | 203 | 0.230 |
Why?
| | Receptors, Dopamine D1 | 1 | 2006 | 34 | 0.230 |
Why?
| | Mothers | 3 | 2019 | 771 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 2 | 2020 | 574 | 0.230 |
Why?
| | Aggression | 4 | 2022 | 170 | 0.220 |
Why?
| | Tobacco Use | 2 | 2024 | 67 | 0.220 |
Why?
| | Research Subjects | 2 | 2015 | 42 | 0.220 |
Why?
| | Environment | 5 | 2012 | 295 | 0.220 |
Why?
| | Personality Disorders | 1 | 2025 | 79 | 0.220 |
Why?
| | Registries | 1 | 2014 | 2382 | 0.210 |
Why?
| | Child Behavior Disorders | 3 | 2011 | 117 | 0.210 |
Why?
| | Substance Abuse Treatment Centers | 3 | 2012 | 48 | 0.210 |
Why?
| | Linkage Disequilibrium | 7 | 2021 | 257 | 0.210 |
Why?
| | Genome | 1 | 2006 | 307 | 0.210 |
Why?
| | Psychotic Disorders | 1 | 2026 | 181 | 0.200 |
Why?
| | Child | 24 | 2025 | 22638 | 0.200 |
Why?
| | Personality | 1 | 2025 | 132 | 0.200 |
Why?
| | Twins, Monozygotic | 5 | 2010 | 132 | 0.200 |
Why?
| | Genomics | 3 | 2020 | 851 | 0.200 |
Why?
| | Age of Onset | 5 | 2018 | 557 | 0.200 |
Why?
| | Internationality | 2 | 2022 | 156 | 0.200 |
Why?
| | Risk Factors | 13 | 2025 | 10840 | 0.200 |
Why?
| | Interview, Psychological | 4 | 2013 | 93 | 0.200 |
Why?
| | Genetic Loci | 3 | 2022 | 272 | 0.190 |
Why?
| | Obesity | 1 | 2017 | 3123 | 0.190 |
Why?
| | Adoption | 1 | 2003 | 25 | 0.190 |
Why?
| | Alleles | 8 | 2018 | 900 | 0.190 |
Why?
| | Gene Frequency | 6 | 2016 | 495 | 0.190 |
Why?
| | Heroin | 1 | 2003 | 30 | 0.190 |
Why?
| | Narcotics | 1 | 2003 | 57 | 0.190 |
Why?
| | Models, Genetic | 6 | 2010 | 537 | 0.190 |
Why?
| | Nerve Tissue Proteins | 5 | 2013 | 594 | 0.180 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 61 | 0.180 |
Why?
| | Incidence | 4 | 2018 | 2910 | 0.170 |
Why?
| | Age Factors | 6 | 2014 | 3321 | 0.170 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 46 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 314 | 0.160 |
Why?
| | Public Health | 1 | 2006 | 573 | 0.160 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 44 | 0.160 |
Why?
| | Monoamine Oxidase | 2 | 2013 | 27 | 0.150 |
Why?
| | Middle Aged | 15 | 2025 | 36359 | 0.150 |
Why?
| | Health Risk Behaviors | 1 | 2019 | 13 | 0.150 |
Why?
| | Twins, Dizygotic | 4 | 2010 | 108 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 50 | 0.150 |
Why?
| | Nausea | 1 | 2020 | 111 | 0.150 |
Why?
| | Autistic Disorder | 1 | 2022 | 215 | 0.140 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 197 | 0.140 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.140 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 8 | 0.140 |
Why?
| | Expressed Emotion | 1 | 2018 | 15 | 0.140 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 33 | 0.140 |
Why?
| | Mortality, Premature | 1 | 2018 | 14 | 0.140 |
Why?
| | Depression | 3 | 2022 | 1566 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 452 | 0.140 |
Why?
| | Multimodal Imaging | 1 | 2019 | 138 | 0.140 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 111 | 0.130 |
Why?
| | HIV Infections | 1 | 2013 | 3210 | 0.130 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 162 | 0.130 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 130 | 0.130 |
Why?
| | Urine | 1 | 2017 | 63 | 0.130 |
Why?
| | Pregnancy | 5 | 2022 | 7217 | 0.130 |
Why?
| | Cannabinoids | 2 | 2017 | 181 | 0.130 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 67 | 0.130 |
Why?
| | Unsafe Sex | 2 | 2016 | 62 | 0.130 |
Why?
| | Bioethics | 1 | 2017 | 26 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 179 | 0.120 |
Why?
| | Biomedical Research | 2 | 2014 | 724 | 0.120 |
Why?
| | Suicide | 2 | 2021 | 638 | 0.120 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1136 | 0.120 |
Why?
| | Gene-Environment Interaction | 2 | 2020 | 188 | 0.120 |
Why?
| | Counseling | 1 | 2020 | 403 | 0.120 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 37 | 0.120 |
Why?
| | Administration, Oral | 1 | 2019 | 867 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2020 | 6449 | 0.120 |
Why?
| | Brain Mapping | 1 | 2019 | 540 | 0.120 |
Why?
| | Drug Storage | 1 | 2016 | 52 | 0.110 |
Why?
| | Mental Competency | 1 | 2015 | 28 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 222 | 0.110 |
Why?
| | Brain | 2 | 2019 | 2981 | 0.110 |
Why?
| | Self Report | 2 | 2018 | 869 | 0.110 |
Why?
| | Patient Admission | 2 | 2012 | 216 | 0.110 |
Why?
| | Surgical Procedures, Operative | 1 | 2018 | 271 | 0.110 |
Why?
| | Exploratory Behavior | 2 | 2013 | 86 | 0.110 |
Why?
| | Life Change Events | 1 | 2016 | 144 | 0.110 |
Why?
| | Drug Overdose | 2 | 2018 | 376 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 715 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 774 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 306 | 0.110 |
Why?
| | Conflict of Interest | 1 | 2014 | 52 | 0.100 |
Why?
| | Automobile Driving | 1 | 2016 | 156 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2018 | 698 | 0.100 |
Why?
| | Informed Consent | 1 | 2015 | 194 | 0.100 |
Why?
| | Medicine | 1 | 2016 | 126 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2007 | 926 | 0.100 |
Why?
| | Netherlands | 1 | 2014 | 84 | 0.100 |
Why?
| | Regression Analysis | 3 | 2019 | 994 | 0.100 |
Why?
| | Cohort Studies | 6 | 2021 | 6045 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2019 | 605 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 3 | 2019 | 1370 | 0.100 |
Why?
| | Time Factors | 3 | 2019 | 7079 | 0.100 |
Why?
| | Aged | 6 | 2018 | 26251 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 491 | 0.100 |
Why?
| | Proteomics | 1 | 2020 | 1202 | 0.100 |
Why?
| | Temperament | 1 | 2013 | 40 | 0.090 |
Why?
| | Condoms | 1 | 2013 | 99 | 0.090 |
Why?
| | Receptors, GABA-A | 1 | 2014 | 138 | 0.090 |
Why?
| | Emotions | 2 | 2021 | 555 | 0.090 |
Why?
| | Patient Safety | 1 | 2016 | 351 | 0.090 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 20 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2910 | 0.090 |
Why?
| | Family Conflict | 1 | 2012 | 43 | 0.090 |
Why?
| | Sexual Partners | 1 | 2013 | 195 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1531 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1323 | 0.090 |
Why?
| | Family Relations | 1 | 2012 | 87 | 0.090 |
Why?
| | Educational Status | 1 | 2013 | 466 | 0.080 |
Why?
| | Pentachlorophenol | 1 | 1990 | 11 | 0.080 |
Why?
| | Nicotine | 3 | 2026 | 334 | 0.080 |
Why?
| | Logistic Models | 4 | 2019 | 2112 | 0.080 |
Why?
| | Ethanol | 2 | 2012 | 629 | 0.080 |
Why?
| | Psychometrics | 3 | 2009 | 708 | 0.080 |
Why?
| | Dizziness | 1 | 2010 | 93 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 558 | 0.070 |
Why?
| | Sample Size | 2 | 2022 | 123 | 0.070 |
Why?
| | Genetic Markers | 2 | 2007 | 337 | 0.070 |
Why?
| | Models, Statistical | 2 | 2010 | 667 | 0.070 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 39 | 0.070 |
Why?
| | Taq Polymerase | 2 | 2006 | 8 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4329 | 0.070 |
Why?
| | Hospitalization | 1 | 2019 | 2468 | 0.070 |
Why?
| | Child Abuse, Sexual | 1 | 2009 | 81 | 0.070 |
Why?
| | Suicidal Ideation | 3 | 2021 | 524 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3917 | 0.070 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 8 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1768 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 14 | 0.060 |
Why?
| | Methylphenidate | 2 | 2004 | 48 | 0.060 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 57 | 0.060 |
Why?
| | Stress, Psychological | 1 | 2016 | 1169 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2008 | 277 | 0.060 |
Why?
| | Risk | 2 | 2020 | 917 | 0.060 |
Why?
| | Retrospective Studies | 8 | 2021 | 17291 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 2357 | 0.060 |
Why?
| | Schizophrenia | 2 | 2022 | 476 | 0.060 |
Why?
| | Family | 4 | 2016 | 680 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 152 | 0.060 |
Why?
| | Child of Impaired Parents | 1 | 2006 | 38 | 0.060 |
Why?
| | Quality of Life | 1 | 2019 | 3187 | 0.060 |
Why?
| | Cheek | 1 | 2006 | 14 | 0.060 |
Why?
| | Fathers | 1 | 2006 | 53 | 0.060 |
Why?
| | Social Facilitation | 1 | 2006 | 10 | 0.060 |
Why?
| | Lysergic Acid Diethylamide | 1 | 2006 | 4 | 0.060 |
Why?
| | Sodium Oxybate | 1 | 2006 | 5 | 0.060 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 11 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 250 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 125 | 0.060 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 159 | 0.060 |
Why?
| | Genetics, Population | 1 | 2007 | 225 | 0.060 |
Why?
| | Central Nervous System Stimulants | 2 | 2004 | 183 | 0.060 |
Why?
| | Poverty | 2 | 2019 | 530 | 0.060 |
Why?
| | Religion | 1 | 2006 | 64 | 0.060 |
Why?
| | Confidence Intervals | 2 | 2006 | 328 | 0.050 |
Why?
| | Parenting | 1 | 2009 | 309 | 0.050 |
Why?
| | Methamphetamine | 1 | 2006 | 75 | 0.050 |
Why?
| | Parents | 2 | 2004 | 1393 | 0.050 |
Why?
| | Suicide, Attempted | 1 | 2008 | 374 | 0.050 |
Why?
| | Universities | 1 | 2007 | 450 | 0.050 |
Why?
| | Beta Rhythm | 1 | 2004 | 33 | 0.050 |
Why?
| | Ketamine | 1 | 2006 | 141 | 0.050 |
Why?
| | Pain Management | 2 | 2019 | 413 | 0.050 |
Why?
| | Marriage | 1 | 2004 | 122 | 0.050 |
Why?
| | Data Interpretation, Statistical | 3 | 2010 | 365 | 0.050 |
Why?
| | Drug Tolerance | 1 | 2003 | 99 | 0.050 |
Why?
| | Genome, Human | 2 | 2020 | 425 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2019 | 11744 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 153 | 0.040 |
Why?
| | Europe | 1 | 2022 | 420 | 0.040 |
Why?
| | Infant | 3 | 2021 | 10093 | 0.040 |
Why?
| | Models, Psychological | 2 | 2016 | 290 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1992 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2097 | 0.040 |
Why?
| | Personality Assessment | 2 | 2013 | 75 | 0.040 |
Why?
| | Loneliness | 1 | 2022 | 69 | 0.040 |
Why?
| | Calibration | 1 | 2021 | 154 | 0.040 |
Why?
| | Methadone | 1 | 2002 | 130 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 495 | 0.040 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1318 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5397 | 0.040 |
Why?
| | Electroencephalography | 1 | 2003 | 570 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1030 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 424 | 0.040 |
Why?
| | Minnesota | 1 | 2020 | 167 | 0.040 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 70 | 0.040 |
Why?
| | Dangerous Behavior | 1 | 2018 | 15 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2022 | 281 | 0.040 |
Why?
| | Drug Utilization Review | 1 | 2019 | 60 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2019 | 118 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2019 | 151 | 0.030 |
Why?
| | Electronic Mail | 1 | 2018 | 63 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 158 | 0.030 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 25 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 423 | 0.030 |
Why?
| | Factor Analysis, Statistical | 2 | 2010 | 295 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 132 | 0.030 |
Why?
| | Preoperative Period | 1 | 2018 | 150 | 0.030 |
Why?
| | Limit of Detection | 1 | 2017 | 92 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 97 | 0.030 |
Why?
| | Gene Expression | 2 | 2016 | 1461 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 344 | 0.030 |
Why?
| | Executive Function | 1 | 2021 | 461 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2010 | 512 | 0.030 |
Why?
| | Chromosome Mapping | 2 | 2008 | 505 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11888 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 34 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 455 | 0.030 |
Why?
| | California | 1 | 2017 | 473 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 1066 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 502 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 162 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 375 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 588 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 148 | 0.030 |
Why?
| | Reward | 1 | 2017 | 242 | 0.030 |
Why?
| | Psychology, Adolescent | 1 | 2015 | 58 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 310 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 1581 | 0.030 |
Why?
| | Violence | 1 | 2018 | 275 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 180 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 138 | 0.030 |
Why?
| | Demography | 1 | 2015 | 274 | 0.030 |
Why?
| | Thoracic Surgical Procedures | 1 | 2016 | 95 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1118 | 0.030 |
Why?
| | Sexually Transmitted Diseases | 1 | 2016 | 163 | 0.030 |
Why?
| | Disclosure | 1 | 2014 | 88 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 229 | 0.020 |
Why?
| | Aging | 1 | 2004 | 1983 | 0.020 |
Why?
| | Arsenites | 1 | 1993 | 6 | 0.020 |
Why?
| | Arsenic Poisoning | 1 | 1993 | 7 | 0.020 |
Why?
| | Cotinine | 1 | 2013 | 77 | 0.020 |
Why?
| | Arsenicals | 1 | 1993 | 28 | 0.020 |
Why?
| | Gluconeogenesis | 1 | 1993 | 81 | 0.020 |
Why?
| | Risk Assessment | 2 | 2015 | 3678 | 0.020 |
Why?
| | Chelating Agents | 1 | 1993 | 75 | 0.020 |
Why?
| | Child Behavior | 2 | 2005 | 234 | 0.020 |
Why?
| | Kidney Tubules | 1 | 1993 | 117 | 0.020 |
Why?
| | Psychological Theory | 1 | 2013 | 95 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2016 | 560 | 0.020 |
Why?
| | Probability | 1 | 2013 | 308 | 0.020 |
Why?
| | Privacy | 1 | 2012 | 41 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1481 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2016 | 728 | 0.020 |
Why?
| | Students | 1 | 2017 | 647 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 507 | 0.020 |
Why?
| | Antidotes | 1 | 1993 | 145 | 0.020 |
Why?
| | Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| | Software | 1 | 2016 | 673 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2857 | 0.020 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3396 | 0.020 |
Why?
| | Chromatography, Gas | 1 | 1990 | 30 | 0.020 |
Why?
| | Sensation | 1 | 2010 | 56 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 316 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1212 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4331 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1130 | 0.020 |
Why?
| | Exercise | 1 | 2021 | 2206 | 0.020 |
Why?
| | Negotiating | 1 | 2009 | 34 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 127 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 467 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 991 | 0.020 |
Why?
| | Molecular Structure | 1 | 1990 | 483 | 0.020 |
Why?
| | Epistasis, Genetic | 1 | 2009 | 66 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 132 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2007 | 84 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 973 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1293 | 0.010 |
Why?
| | Odds Ratio | 1 | 2009 | 1070 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2009 | 266 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 751 | 0.010 |
Why?
| | Rats | 2 | 1993 | 5574 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 847 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 787 | 0.010 |
Why?
| | Schools | 1 | 2006 | 436 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2004 | 159 | 0.010 |
Why?
| | Research Design | 1 | 2009 | 1139 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8351 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2004 | 511 | 0.010 |
Why?
| | Housing | 1 | 2004 | 141 | 0.010 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 59 | 0.010 |
Why?
| | Family Characteristics | 1 | 2004 | 202 | 0.010 |
Why?
| | Attention | 1 | 2004 | 459 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1429 | 0.010 |
Why?
| | DNA | 1 | 2007 | 1418 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1843 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2003 | 547 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 2064 | 0.010 |
Why?
| | Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| | Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| | Dimercaprol | 1 | 1993 | 6 | 0.010 |
Why?
| | Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 1993 | 384 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1993 | 195 | 0.010 |
Why?
| | Arsenic | 1 | 1993 | 66 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1993 | 1041 | 0.010 |
Why?
| | Animals | 2 | 1993 | 38030 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1993 | 2533 | 0.000 |
Why?
| | Mice | 1 | 1993 | 18266 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|